23 results
SC TO-T/A
EX-99
Concentra Merger Sub II, Inc.
14 Feb 24
Third party tender offer statement (amended)
10:35am
:
(a) the expenditure of $386,705 for (i) Disposition business development efforts related to the CVR Products, (ii) the retention of an employee or consultant
SC TO-T/A
EX-99
Concentra Merger Sub II, Inc.
30 Jan 24
Third party tender offer statement (amended)
8:23am
with respect to: (i) Disposition business development efforts related to the CVR Products, (ii) the retention of an employee or consultant of Parent … , (D) pay or award, or commit to pay or award, any bonuses or incentive or equity compensation, (E) enter into any employment, retention, consulting
SC 14D9
THRX
Theseus Pharmaceuticals Inc
10 Jan 24
Tender offer solicitation
9:47am
agreements;
With respect to Mr. Dahms, a retention bonus in the amount of $702,000, subject to his continued employment through the earlier of February 28 … shall continue to vest in accordance with the applicable purchase, award or grant agreement during the Shakespeare Consulting Period.
Retention Bonus
SC TO-T
EX-99
Concentra Merger Sub II, Inc.
10 Jan 24
Third party tender offer statement
8:51am
of the Company or any of its subsidiaries relating to (i) any retention, severance, equity or other compensation, incentives or benefits that may
SC TO-T
EX-99
Concentra Merger Sub II, Inc.
10 Jan 24
Third party tender offer statement
8:51am
the CVR Agreement with respect to: (i) Disposition business development efforts related to the CVR Products, (ii) the retention of an employee … , or commit to pay or award, any bonuses or incentive or equity compensation, (E) enter into any employment, retention, consulting, change in control
8-K
EX-2.1
1es3ug
22 Dec 23
Entry into a Material Definitive Agreement
6:36am
8-K
arssne1fnzi1 lx
4 Dec 23
Departure of Directors or Certain Officers
6:30am
PRE 14A
usscwkp
14 Apr 23
Preliminary proxy
9:00am
DEF 14A
g2s1w8vamk57yh0 7ndh
25 Apr 22
Definitive proxy
4:30pm
10-K
lvhfysvgp1hfaau4
10 Mar 22
Annual report
7:23am
10-Q
ocip4w3flxrr0h8ib5t
15 Nov 21
Quarterly report
7:36am
424B4
8tgn at1v
7 Oct 21
Prospectus supplement with pricing info
5:03pm
S-1/A
60ihtjmx
30 Sep 21
IPO registration (amended)
6:33am
S-1/A
EX-10.3
wi6bbwu
30 Sep 21
IPO registration (amended)
6:33am
S-1/A
EX-1.1
3ain0
30 Sep 21
IPO registration (amended)
6:33am
S-1
373dn
15 Sep 21
IPO registration
4:04pm
S-1
EX-10.6
gpqzaesjq
15 Sep 21
IPO registration
4:04pm
S-1
EX-10.2
b4j wlfpvjxhnx
15 Sep 21
IPO registration
4:04pm
DRS/A
o3j6hucs2u3yqlilc2b
23 Aug 21
Draft registration statement (amended)
12:00am